Topical ranibizumab as a treatment of corneal neovascularization
about
Corneal neovascularization and biological therapyCorneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin)Ranibizumab for the treatment of degenerative ocular conditions.Ranibizumab injection for corneal neovascularization refractory to bevacizumab treatment.Topical versus subconjunctival anti-vascular endothelial growth factor therapy (Bevacizumab, Ranibizumab and Aflibercept) for treatment of corneal neovascularization.Growth inhibition of formed corneal neovascularization following Fosaprepitant treatment.Recent drug therapies for corneal neovascularization.Topical and subconjunctival ranibizumab (lucentis) for corneal neovascularization in experimental rat model.Anti-VEGF Agents for the Treatment of Pigment Epithelial Detachments Associated with Neovascular Age-related Macular Degeneration: An Evidence-based Approach.Therapeutic approaches for corneal neovascularization.Differential Effects of Bevacizumab, Ranibizumab, and Aflibercept on the Viability and Wound Healing of Corneal Epithelial Cells.Photokinetic Drug Delivery: Near infrared (NIR) Induced Permeation Enhancement of Bevacizumab, Ranibizumab and Aflibercept through Human Sclera.Self-implantable double-layered micro-drug-reservoirs for efficient and controlled ocular drug delivery
P2860
Q26776229-AC819912-9CEC-4C9C-B2EA-ED7799639CF6Q26823757-4E9F3226-ED0F-46FA-B6CD-2B4798AE9E63Q33831237-F48B2D9C-D8C6-4830-85CA-0B329C1C1D35Q37644799-4B44DBCF-CEAF-4B5A-A62E-D544FE0D1B7CQ38755418-2F7C616A-518D-4877-AA21-83D70CA16BFDQ38958273-41AE7CCD-1703-473A-B07E-65B55257B481Q39295602-61240CC1-DA58-4707-8DA4-706DA0EC59CDQ40124848-BBD21695-532D-4795-848E-9E5CB62DC511Q42377720-CB5E25DF-62F6-440F-843B-DF684A25B1E1Q47143268-329227A8-BD2F-4E36-A4D5-EBD1176B2F34Q47162407-07D42D8C-3007-4CBE-B5DC-FE9FF4DA9DC3Q55353695-AC2243D1-9D5F-4893-9F0B-60685ABF5D40Q58608160-2669F27B-01C9-49CC-A8B0-2540045BB718
P2860
Topical ranibizumab as a treatment of corneal neovascularization
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Topical ranibizumab as a treatment of corneal neovascularization
@en
Topical ranibizumab as a treatment of corneal neovascularization.
@nl
type
label
Topical ranibizumab as a treatment of corneal neovascularization
@en
Topical ranibizumab as a treatment of corneal neovascularization.
@nl
prefLabel
Topical ranibizumab as a treatment of corneal neovascularization
@en
Topical ranibizumab as a treatment of corneal neovascularization.
@nl
P2093
P2860
P1433
P1476
Topical ranibizumab as a treatment of corneal neovascularization
@en
P2093
Andre Okanobo
Francisco Amparo
Giulio Ferrari
Mohammad H Dastjerdi
Nambi Nallasamy
Sheng-Fu Cheng
P2860
P304
P356
10.1097/ICO.0B013E3182775F8D
P577
2013-07-01T00:00:00Z